Elma Mons

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Venues

Pharmaceuticals (Basel, Switzerland)

Science translational medicine

Journal of the American Chemical Society

Current protocols

Leiden University Medical Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Leiden University Medical Center

Netherlands

PhD student :: Department of Cell and Chemical Biology

Publications

Emma van Groesen, Elma Mons, Ioli Kotsogianni, Melina Arts, Kamaleddin H M E Tehrani, Nicola Wade, Vladyslav Lysenko, Florence M Stel, Jordy T Zwerus, Stefania De Benedetti, Alexander Bakker, Parichita Chakraborty, Mario van der Stelt, Dirk-Jan Scheffers, Jairo Gooskens, Wiep Klaas Smits, Kirsty Holden, Peter S Gilmour, Joost J Willemse, Christopher A Hitchcock, Johan G C van Hasselt, Tanja Schneider, Nathaniel I Martin
Semisynthetic guanidino lipoglycopeptides with potent in vitro and in vivo antibacterial activity. Science translational medicine 16 (759) (2024)
Emma van Groesen, Elma Mons, Ioli Kotsogianni, Melina Arts, Kamaleddin H M E Tehrani, Nicola Wade, Vladyslav Lysenko, Florence M Stel, Jordy T Zwerus, Stefania De Benedetti, Alexander Bakker, Parichita Chakraborty, Mario van der Stelt, Dirk-Jan Scheffers, Jairo Gooskens, Wiep Klaas Smits, Kirsty Holden, Peter S Gilmour, Joost J Willemse, Christopher A Hitchcock, Johan G C van Hasselt, Tanja Schneider, Nathaniel I Martin
Semisynthetic guanidino lipoglycopeptides with potent in vitro and in vivo antibacterial activity. Science translational medicine 16 (759) (2024)
Elma Mons, Robbert Q Kim, Monique P C Mulder
Technologies for Direct Detection of Covalent Protein-Drug Adducts. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Elma Mons, Robbert Q Kim, Monique P C Mulder
Technologies for Direct Detection of Covalent Protein-Drug Adducts. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Elma Mons, Robbert Q Kim, Monique P C Mulder
Technologies for Direct Detection of Covalent Protein-Drug Adducts. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Elma Mons, Robbert Q Kim, Monique P C Mulder
Technologies for Direct Detection of Covalent Protein-Drug Adducts. Pharmaceuticals (Basel, Switzerland) 16 (4) (2023)
Elma Mons, Sander Roet, Robbert Q Kim, Monique P C Mulder
A Comprehensive Guide for Assessing Covalent Inhibition in Enzymatic Assays Illustrated with Kinetic Simulations. Current protocols 2 (6) (2022)
Elma Mons, Robbert Q Kim, Bjorn R van Doodewaerd, Peter A van Veelen, Monique P C Mulder, Huib Ovaa
Exploring the Versatility of the Covalent Thiol-Alkyne Reaction with Substituted Propargyl Warheads: A Deciding Role for the Cysteine Protease. Journal of the American Chemical Society 143 (17) (2021)
Elma Mons, Ineke D C Jansen, Jure Loboda, Bjorn R van Doodewaerd, Jill Hermans, Martijn Verdoes, Constant A A van Boeckel, Peter A van Veelen, Boris Turk, Dusan Turk, Huib Ovaa
The Alkyne Moiety as a Latent Electrophile in Irreversible Covalent Small Molecule Inhibitors of Cathepsin K. Journal of the American Chemical Society 141 (8) (2019)

Elma Mons.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Elma Mons